The main purpose of the study is to determine whether the experimental study drug, AI-081, is safe and well tolerated, and whether it is effective in treating advanced cancer that cannot be removed by surgery or has spread to a different part of the body (metastasis).
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Shetal Patel
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Lung)
25-0235
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
